📺François Toujas, président de l'@EFS_Sante , confirme sur @telematin les besoins en dons de sang et signale que la production de sang n'a pas encore la capacité de les remplacer.
@EryPharm y travaille et cherche son financement!
https://t.co/LrYB1kW9LN
#frenchtech#biotech
💥Niveau critique des stocks de #sang pour les transfusions : Erypharm propose LA solution avec la culture industrielle de globules rouges à partir de cellules souches. Investisseurs contactez-nous pour soutenir cette #innovation stratégique pour la #santé https://t.co/2ErcANyqLW
@Europe1 présente EryPharm en réaction à la pénurie actuelle de sang annoncée par l'@EFS_dondesang :
https://t.co/ZREcA6VLYx
N'hésitez pas revenir sur notre site pour découvrir notre technologie: https://t.co/9OUMLgdMVp
Congratulation to our peers from the University of Bristol
A very clear overview of what could be the future of transfusion.
#erypharm is taking over 💪
This review discusses recent progress in the erythroid culture field as well as opportunities for further scaling up of manufactured #RBC production for transfusion practice.
https://t.co/iYTwBUHPe4
This review discusses recent progress in the erythroid culture field as well as opportunities for further scaling up of manufactured #RBC production for transfusion practice.
https://t.co/iYTwBUHPe4
Remember last week?
https://t.co/u5caFJCHvA
It represents 500 billion purified cultured Red Blood Cells 🩸
Manufactured in bioreactors of 10 L in total, it is a 20-fold improvement of scientific gold-standard in terms of volumetric efficiency.
🚀 In a nutshell, Rocket Science! 🚀
🧬With Erypharm, justify your financial investment by supporting the development of a major innovation: the mass production of cultured red blood cells. More than a new drug, it is a new paradigm for transfusion medicine.
#biotech#investment
📲https://t.co/KcAA46mSIZ
⚡️Erypharm: a financial investment that creates societal value. Erypharm is leading a revolutionary breakthrough in the mass production of cultured red blood cells. More than a new drug, it is a new model for transfusion medicine.
📲https://t.co/KcAA46mSIZ
💥 Erypharm: a meaningful investment. Erypharm has achieved a revolutionary breakthrough in the mass production of cultured red blood cells. More than a new drug, it is a new model for transfusion medecine
#biotech#innovation#investment
🚨Erypharm is leading a revolutionary breakthrough in the mass production of cultured red blood cells. More than a new drug, it is a new model for transfusion medicine.
#startup#innovation#biotech